02.08.2023 Temedica and AbbVie Germany are launching digital companion for patients with chronic inflammatory bowel diseases
15.12.2022 Temedica's CEO, Gloria Seibert, is listed on Manager Magazin's "Top 100 most influential Women"
23.11.2022 Temedica raises another €25 million in Series B funding to expand its unique real-world insights ecosystem
